LINKAGE TO PRIMARY CARE FOR PERSONS FIRST RECEIVING INJECTABLE NALTREXONE DURING INPATIENT OPIOID DETOXIFICATION

INTRODUCTION: Opioid use disorders commonly require ongoing medication-assisted treatment to reduce relapse following discharge from inpatient detoxification programs. Naltrexone, an opioid antagonist, is an increasingly popular treatment option in its once-monthly injectable form (XR-NTX). The aim...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Subst Abuse Treat
Auteurs principaux: Stein, Michael D., Risi, Megan M., Bailey, Genie L., Anderson, Bradley J.
Format: Artigo
Langue:Inglês
Publié: 2016
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4818184/
https://ncbi.nlm.nih.gov/pubmed/26920817
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsat.2016.01.007
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires